Previous Article | Next Article ![]()
Journal of Bacteriology, August 1998, p. 4291-4293, Vol. 180, No. 16
Laboratoire de Chimie Structurale des
Macromolécules,
Received 15 April 1998/Accepted 12 June 1998
The wild-type TMP kinases from Escherichia coli and
from a strain hypersensitive to 5-bromo-2'-deoxyuridine were
characterized comparatively. The mutation at codon 146 causes the
substitution of an alanine residue for glycine in the enzyme, which is
accompanied by changes in the relative affinities for 5-Br-UMP and TMP
compared to those of the wild-type TMP kinase. Plasmids carrying the
wild-type tmk gene from Escherichia coli or
Bacillus subtilis, but not the defective tmk
gene, restored the resistance to bromodeoxyuridine of an E. coli mutant strain.
Nucleoside monophosphate (NMP)
kinases are key catalysts involved in the cellular turnover of
nucleotides (1, 10). Considered homologous enzymes with
adenylate kinase as the paradigm, bacterial NMP kinases exhibit in fact
high variability, both in their structures and their catalytic
properties (3, 5, 6, 15). The most striking example is UMP
kinase from Escherichia coli, a homohexamer subject to
complex allosteric regulation (16).
TMP kinase represents approximately 0.01% of soluble proteins in
E. coli, a percentage 10 to 20 times less than that for
adenylate kinase, the most abundant NMP kinase. The tmk gene
from this bacterium was recently cloned and sequenced (12),
thus opening the way for structural and functional analysis of the
enzyme, either isolated or within the intact organism.
In this paper we characterize comparatively the wild-type TMP kinase
and a modified form recognized as inducing the hypersensitivity of
E. coli to 5-bromo-2'-deoxyuridine (BUdR) (4).
Our objective was to correlate the changes in the structural properties
of TMP kinase with altered kinetics and with bacterial hypersensitivity to a nucleoside analog.
Molecular cloning and DNA sequencing of the tmk gene
from strain TD205 of E. coli.
A
tmk-defective mutant (TD205) was isolated after
nitrosoguanidine mutagenesis of strain LD0181 of E. coli. It had low TMP kinase activity, accompanied by an
elevated pool of TMP and hypersensitivity to BUdR, compared to
the parent bacterium (4). To identify the site of the
mutation, the tmk gene from E. coli was amplified by PCR with chromosomal DNA from strains NM554 (11) and
TD205 (4) as the matrix. The PCR products were inserted
in expression vector pET22b (Novagen), giving plasmids
pBLT1110 and pBLT1120, respectively (Table
1). The sequences of cloned
tmk genes were verified by the dideoxynucleotide sequencing
method (14). The sequence of the tmk gene from
strain NM554 was found to be identical to that previously published
(12), whereas that of strain TD205 revealed a G Overproduction and molecular characterization of wild-type TMP
kinase and of the G146A variant.
Plasmids harboring tmk
genes were introduced into E. coli BL21(DE3)/pDIA17.
Bacteria were grown at 37°C in 2YT medium (13) supplemented with ampicillin (100 µg/ml) and chloramphenicol (30 µg/ml). When the optical density at 600 nm reached 1.5, isopropyl-
0021-9193/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Substitution of an Alanine Residue for Glycine 146 in TMP Kinase
from Escherichia coli Is Responsible for Bacterial
Hypersensitivity to Bromodeoxyuridine

![]()
ABSTRACT
Top
Abstract
Text
References
![]()
TEXT
Top
Abstract
Text
References
C
transversion at codon 146, responsible for the substitution in the
protein of an alanine residue for glycine at position 146 (G146A
substitution).
TABLE 1.
Strains and plasmids
-D-thiogalactoside (final concentration, 1 mM)
was added to the medium, and the culture was further incubated at
37°C for 3 h. The recombinant enzymes, representing about 30%
of total soluble proteins, were purified by Affi-Gel Blue and Ultrogel
AcA54 chromatography (2) with the following modification:
the enzymes adsorbed onto Affi-Gel Blue were eluted with 2 M NaCl in 50 mM Tris-HCl (pH 7.4). The N-terminal amino acid residues
(Met-Arg-Ser-Lys-Tyr-Ile-Val-Ile) determined by Edman sequencing
corresponded to those deduced from the tmk gene. The
molecular masses of TMP kinase measured by electrospray ionization mass
spectrometry (23779.6 ± 0.8 Da for the wild-type enzyme and
23794.4 ± 1.4 Da for the G146A mutant) were in agreement with
those calculated from the sequences. Gel permeation chromatography and
sedimentation equilibrium centrifugation indicated a molecular mass of
48 kDa for each of the two proteins. In other words TMP kinase from
E. coli, like the enzyme from other sources, is a homodimer.
Inactivation of TMP kinase by tolylsulfonyl phenylalanyl chloromethyl
ketone (TPCK)-trypsin followed first-order kinetics: k1 = 4.1 × 10
3
s
1 for the wild-type protein and 1.7 × 10
3 s
1 for the G146A mutant. Two fragments
resistant to further proteolysis were accumulated as shown by sodium
dodecyl sulfate-polyacrylamide gel electrophoresis (Fig.
1). The sizes of fragments are identical in the two TMP kinases, suggesting the same site of proteolytic attack.
N-terminal sequencing of fragments after electroblot transfer indicated
that TMP kinase was cleaved in an arginine-rich segment, 147LKRARARG154 (Fig.
2). Compared to adenylate kinase and CMP
kinase from the same bacterium (3), TMP kinase was less
protected against proteolytic inactivation by ATP or other nucleotides.
The midpoint denaturation temperatures of TMP kinase determined by
differential scanning calorimetry were 57.5°C for the wild-type
protein and 60.0°C for the G146A form. Denaturation of TMP kinase by
urea is reversible and accompanied by a shift in the maximum of Trp
fluorescence, the midpoint transition being at 3.0 M urea for the
wild-type enzyme and at 3.3 M for the G146A mutant.

View larger version (75K):
[in a new window]
FIG. 1.
Proteolysis of E. coli TMP kinase by
TPCK-trypsin. TMP kinase (wild-type enzyme, lanes 1 to 3; G146A
variant, lanes 4 to 6) at 1 mg/ml in 50 mM Tris-HCl (pH 7.4) was
incubated at 16°C with TPCK-trypsin (2 µg/ml). At different times
(0 min, lanes 1 and 4; 2 min, lane 2; 5 min, lane 5; 6 min, lane 3; 15 min, lane 6) 10-µl aliquots were withdrawn, boiled with
electrophoresis buffer, and analyzed by sodium dodecyl sulfate-12.5%
polyacrylamide gel electrophoresis and Coomassie blue staining. The
arrows indicate the standard proteins (molecular weights are in
parentheses): A, phosphorylase a (94,000); B, bovine serum
albumin (68,000); C, ovalbumin (43,000); D, carbonic anhydrase
(30,000); E, soybean trypsin inhibitor (20,100); and F, lysozyme
(14,400).

View larger version (26K):
[in a new window]
FIG. 2.
Alignment of amino acid sequences in four forms of TMP
kinase. Strictly conserved residues, expressed in one-letter codes, are
outlined, and residues conserved in bacterial TMP kinases are in
boldface. Residues supposed to play a role in catalysis are marked by
asterisks. The trypsin cleavage site is marked by an arrow, and
residues belonging to the LID domain in TMP kinase from
Saccharomyces cerevisiae are underlined. H. influenzae, Haemophilus influenzae.
Catalytic properties of wild-type and of G146A-modified TMP kinase from E. coli. ATP is the best phosphoryl donor of TMP kinase from E. coli. The activity with UTP, GTP, and CTP at a single fixed concentration (1 mM) represented 13, 15, and 24%, respectively, of that with ATP. Of the NMPs tested, TMP and 5-Br-UMP are the best acceptors (Table 2). The other halogenated derivatives of dUMP (5-I-UMP and 5-F-UMP) showed lower Vmax and higher Km values for TMP kinase than those exhibited by 5-Br-UMP (data not shown). The Km for ATP of the wild-type TMP kinase (0.04 mM) was independent of the chemical nature of the cosubstrate. The G146A substitution altered the kinetic parameters of TMP kinase. The Vmax with ATP and TMP decreased by a factor of 5, and the Kms for ATP (0.33 mM) and TMP (0.25 mM) increased by factors of 8 and 17, respectively. More significant, however, is the change in the relative kcat/Km values for 5-Br-UMP and TMP in the two forms of TMP kinase (Table 2). At approximately a twofold excess of 5-Br-UMP over the intracellular pool of TMP in strain TD205, the rate of phosphorylation of 5-Br-UMP will equal that of TMP, whereas for the wild-type strain, a sixfold excess of the analog would have the same effect.
|
Ala substitution affects differently the interactions of the electron-releasing methyl group in TMP and of the electron-withdrawing halogen in 5-Br-dUMP. Therefore, the alteration of the kinetic parameters of TMP kinase resulting from the Gly146
Ala substitution compared to those of the wild-type enzyme might result solely from
local structural changes.
Sensitivity to BUdR of strain TD205 transformed with plasmids carrying the tmk gene. We investigated the ability of different recombinant plasmids carrying the tmk gene from strains NM554 (pBLT1110) and TD205 (pBLT1120) of E. coli and from strain 168 of Bacillus subtilis (pHSP236) to restore the resistance to BUdR of strain TD205. TD205 and derived strains were grown at 37°C in 2YT medium supplemented with tetracycline (10 µg/ml) and ampicillin (100 µg/ml) when required. When the optical density at 600 nm reached 1, diluted samples containing approximately 100 cells were plated on L broth agar containing tetracycline (10 µg/ml), ampicillin (100 µg/ml), and BUdR (20 µg/ml). The wild-type tmk genes from E. coli and B. subtilis restored the BUdR resistance of strain TD205, whereas the gene encoding the G146A variant did not. As TMP kinase from B. subtilis has a specific activity similar to that exhibited by the G146A mutant enzyme (10 U/mg at the optimal substrate concentration) (18), it follows that the BUdR sensitivity of strain TD205 is due to the alteration of TMP kinase substrate specificity and not to a decrease in its specific activity.
| |
ACKNOWLEDGMENTS |
|---|
This work was supported by grants from the Centre National de la Recherche Scientifique (URA 1129) and the Institut Pasteur.
We thank O. Bârzu for carefully reading this manuscript, F. Maraboeuf for microcalorimetry analysis, and M. Ferrand for excellent technical assistance. Strain TD205 of E. coli was kindly provided by the E. coli Genetic Stock Center, Yale University, New Haven, Conn.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Laboratoire de Chimie Structurale des Macromolécules, Institut Pasteur, 28, rue du Docteur Roux, 75724 Paris Cedex 15, France. Phone: 33 (1) 45 68 89 68. Fax: 33 (1) 45 68 84 05. E-mail: amgilles{at}pasteur.fr.
Present address: Institute Cantacuzino, 70100 Bucharest, Romania.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Anderson, E. P. 1973. Nucleoside and nucleotide kinases, p. 49-96. In P. D. Boyer (ed.), The enzymes, vol. 8. Academic Press, New York, N.Y. |
| 2. | Bârzu, O., and S. Michelson. 1983. Simple and fast purification of Escherichia coli adenylate kinase. FEBS Lett. 153:280-284[Medline]. |
| 3. |
Bucurenci, N.,
H. Sakamoto,
P. Briozzo,
N. Palibroda,
L. Serina,
R. S. Sarfati,
G. Labesse,
G. Briand,
A. Danchin,
O. Bârzu, and A.-M. Gilles.
1996.
CMP kinase from Escherichia coli is structurally related to other nucleoside monophosphate kinases.
J. Biol. Chem.
271:2856-2862 |
| 4. |
Daws, T. D., and J. A. Fuchs.
1984.
Isolation and characterization of an Escherichia coli mutant deficient in dTMP kinase activity.
J. Bacteriol.
157:440-444 |
| 5. |
Gentry, D.,
C. Bengra,
K. Ikehara, and M. Cashel.
1993.
Guanylate kinase of Escherichia coli K-12.
J. Biol. Chem.
268:14316-14321 |
| 6. | Glaser, P., E. Presecan, M. Delepierre, W. K. Surewicz, H. H. Mantsch, O. Bârzu, and A.-M. Gilles. 1992. Zinc, a novel structural element found in the family of bacterial adenylate kinases. Biochemistry 31:3038-3043[Medline]. |
| 7. | Kunst, F., et al. 1997. The complete genome sequence of the Gram-positive bacterium Bacillus subtilis. Nature 390:249-256[Medline]. |
| 8. | Lavie, A., M. Konrad, R. Braundiers, R. S. Goody, I. Schlichting, and J. Reinstein. 1998. Crystal structure of yeast thymidylate kinase complexed with the bisubstrate inhibitor P1-(5'-adenosyl)P5-(5'-thymidyl) pentaphosphate (TP5A) at 2.0 Å resolution: implication for catalysis and AZT activation. Biochemistry 37:3677-3686[Medline]. |
| 9. | Munier, H., A.-M. Gilles, P. Glaser, E. Krin, A. Danchin, R. S. Sarfati, and O. Bârzu. 1991. Isolation and characterization of catalytic and calmodulin-binding domains of Bordetella pertussis adenylate cyclase. Eur. J. Biochem. 196:469-474[Medline]. |
| 10. | Neuhard, J., and R. A. Kelln. 1996. Biosynthesis and conversions of pyrimidines, p. 580-599. In F. C. Neidhardt, R. Curtiss III, J. L. Ingraham, E. C. C. Lin, K. B. Low, B. Magasanik, W. S. Reznikoff, M. Riley, M. Schaechter, and H. E. Umbarger (ed.), Escherichia coli and Salmonella: cellular and molecular biology, 2nd ed., vol. 1. American Society for Microbiology, Washington, D.C. |
| 11. |
Raleigh, E. A.,
N. E. Murray,
H. Revel,
R. M. Blumenthal,
D. Westaway,
A. D. Reith,
P. W. J. Rigby,
J. Elhai, and D. Hanahan.
1988.
McrA and McrB restriction phenotypes of some E. coli strains and implications for gene cloning.
Nucleic Acids Res.
16:1563-1575 |
| 12. |
Reynes, J.-P.,
M. Tiraby,
M. Baron,
D. Drocourt, and G. Tiraby.
1996.
Escherichia coli thymidylate kinase: molecular cloning, nucleotide sequence, and genetic organization of the corresponding tmk locus.
J. Bacteriol.
178:2804-2812 |
| 13. | Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y. |
| 14. |
Sanger, F.,
S. Nicklen, and A. R. Coulson.
1977.
DNA sequencing with chain- terminating inhibitors.
Proc. Natl. Acad. Sci. USA
74:5463-5467 |
| 15. | Schulz, G. E., E. Schiltz, A. G. Tomasselli, R. Frank, M. Brune, A. Wittinghofer, and R. H. Schirmer. 1986. Structural relationships in the adenylate kinase family. Eur. J. Biochem. 161:127-132[Medline]. |
| 16. | Serina, L., C. Blondin, E. Krin, O. Sismeiro, A. Danchin, H. Sakamoto, A.-M. Gilles, and O. Bârzu. 1995. Escherichia coli UMP-kinase, a member of the aspartokinase family, is a hexamer regulated by guanine nucleotides and UTP. Biochemistry 34:5066-5074[Medline]. |
| 17. | Studier, F. W., A. H. Rosenberg, J. J. Dunn, and J. W. Dubendorff. 1990. Use of T7 RNA polymerase to direct expression of cloned genes. Methods Enzymol. 185:60-89[Medline]. |
| 18. | Tourneux, L., and A.-M. Gilles. Unpublished data. |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Appl. Environ. Microbiol. | Infect. Immun. | Eukaryot. Cell |
|---|---|---|
| Mol. Cell. Biol. | J. Virol. | Microbiol. Mol. Biol. Rev. |
| ALL ASM JOURNALS |